Acasti Pharma Inc. - Class A





Please Login or Register

Login|Register FREE

Stock Price
Open: 0.71
Prev. Close: 0.71
Low/Hi: 0.71 - 0.80
52-Week: 0.60 - 3.36
Equity: 414,474
90-Day Avg: 282,822
Todays Stock Vol: 119.0
20-Day (HV): 73.6
52-Week (HV): 72.6
Div. Yield:
Earnings: 23-May (Est.)
P/E Ratio:
Market Cap: 18.2 M
Short Int Pct: 0.0%
Pct Held By Inst.: 6.6%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ACST

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population. The corporation's strategy is to initially develop and commercialize CaPre for the three to four million patients in the U.S. with severe hypertriglyceridemia. Since its founding in 2008, Acasti Pharma has focused on addressing a critical market need for an effective, safe and well-absorbing omega-3 therapeutic that can make a positive impact on the major blood lipids associated with cardiovascular disease risk.
Primary Exchange: NASDAQ
NAICS Pharmaceutical Preparation Manufacturing

Wait, Before You Leave...

Want to Know More About ACST Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon